Oxalic Acid

Oxalic Acid

SCHEMBL9613845

COc1ccccc1C(CCOc1cccc2ccccc12)N(C)C.O=C(O)C(=O)O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC6A4 known ✓ P31645 1/20 0.43
KMT2A Q03164 2/20 0.50
ALDH1A1 P00352 5/20 0.49
KDM4E B2RXH2 4/20 0.49
HPGD P15428 3/20 0.49
ATM Q13315 1/20 0.49
HTR1B P28222 5/20 0.48
TDP1 Q9NUW8 1/20 0.46
HTR1D P28221 2/20 0.45
TSHR P16473 1/20 0.43
MCL1 Q07820 1/20 0.43
KCNA3 P22001 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL9614126 0.90 KMT2A (0.49) KMT2AALDH1A1KDM4EHPGDATM
Oxalic Acid SCHEMBL9613944 0.89 KMT2A (0.48) KMT2AALDH1A1KDM4EHPGDATM
Dapoxetine SCHEMBL9614075 0.87 KMT2A (0.59) KMT2AALDH1A1KDM4EHPGDATM
Oxalic Acid SCHEMBL9613762 0.86 SLC6A4 (0.47) KMT2AALDH1A1KDM4EHPGDATM
Oxalic Acid SCHEMBL9613773 0.85 KMT2A (0.50) KMT2AALDH1A1KDM4EHPGDATM
Oxalic Acid SCHEMBL9614095 0.84 KMT2A (0.53) KMT2AALDH1A1KDM4EHPGDATM
Oxalic Acid SCHEMBL9613924 0.84 KMT2A (0.51) KMT2AALDH1A1KDM4EHPGDATM
Oxalic Acid SCHEMBL9613810 0.83 KMT2A (0.52) KMT2AALDH1A1KDM4EHPGDATM
Oxalic Acid SCHEMBL9613984 0.83 KMT2A (0.52) KMT2AALDH1A1KDM4EHPGDATM
Oxalic Acid SCHEMBL9613796 0.82 KMT2A (0.51) KMT2AALDH1A1KDM4EHPGDATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135947-A Treatment of depression, eating disorders, and alcoholism ELI LILLY AND COMPANY (US) 1992-08-04 US disclosed
EP-0288188-B1 1-PHENYL-3-NAPHTHALENYLOXY-PROPANAMINES ELI LILLY AND COMPANY (US) 1991-10-16 EP disclosed
EP-0288188-A1 1-Phenyl-3-naphthalenyloxy-propanamines ELI LILLY AND COMPANY (US) 1988-10-26 EP disclosed